Your Ozempic is set to get cheaper. But with over 50 brands of the same molecule hitting the market this year, which one will be a crowd favourite? Mint decodes.
Recent Posts
- Nasdaq Secures SEC Approval To List Blockchain Version Of Stocks, Including S&P 500-Tracking ETFs
- Dogecoin To $10? Top Analyst Spots Pattern Signaling Big Gains, But This X User Has Questions
- Mukul Agrawal stock jumps 8% after commissioning 1 GW facility with Rs. 1,000 Cr revenue potential
- Mukul Agrawal Stock Jumps 8% After Commissioning Solar Module Facility with ₹1,000 Cr Revenue Potential
- Recently Listed Stock Crashes 15% After Reporting 61% QoQ Decrease in Net Profit